Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
Holding EVLO?
Track your performance easily
EVLO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $7.69
Previous Close$0.06
Volume2.00
Average Volume (3M)131.00
Market Cap
$1.90K
Enterprise Value$16.69M
Total Cash (Recent Filing)$17.26M
Total Debt (Recent Filing)$33.95M
Price to Earnings (P/E)―
Beta29.01
Next Earnings
Aug 01, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.35
Shares Outstanding18,982,837
10 Day Avg. Volume596
30 Day Avg. Volume131
Standard Deviation0.47
R-Squared0.03
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evelo Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVLO FAQ
What was Evelo Biosciences Inc’s price range in the past 12 months?
Evelo Biosciences Inc lowest stock price was $0.03 and its highest was $7.69 in the past 12 months.
What is Evelo Biosciences Inc’s market cap?
Currently, no data Available
When is Evelo Biosciences Inc’s upcoming earnings report date?
Evelo Biosciences Inc’s upcoming earnings report date is Aug 01, 2024 which is 24 days ago.
How were Evelo Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is Evelo Biosciences Inc overvalued?
According to Wall Street analysts Evelo Biosciences Inc’s price is currently Overvalued.
Does Evelo Biosciences Inc pay dividends?
Evelo Biosciences Inc does not currently pay dividends.
What is Evelo Biosciences Inc’s EPS estimate?
Evelo Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evelo Biosciences Inc have?
Evelo Biosciences Inc has 18,982,838 shares outstanding.
What happened to Evelo Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Evelo Biosciences Inc?
Among the largest hedge funds holding Evelo Biosciences Inc’s share is Flagship Pioneering Inc.. It holds Evelo Biosciences Inc’s shares valued at N/A.
---
Evelo Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Evelo Biosciences Inc
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
---
EVLO Earnings Call
Q4 2023
0:00 / 0:00
---
EVLO Stock 12 Month Forecast
Average Price Target
―---